The maker of the Cologuard colon cancer screening test lowered its full-year outlook ... loss of $15.8 million or 9 cents per share in the previous quarter. Analysts surveyed by Visible Alpha ...

Exact Sciences shares plunged Wednesday after the maker of Cologuard reported widening losses and cut its outlook.

Cologuard is an at-home colon cancer screening kit that detects changes in genetic material indicating potential cancer or polyps. Medicare covers one kit per year under Original Medicare (Parts A and ...

your plan will cover one kit every year under Original Medicare (Parts A and B). Anyone enrolled in Medicare ages 45 years and above is eligible for coverage for one Cologuard test annually.

Which mold test kit is best? Mold growth in your home is more than just unpleasant. Foul odors, property damage and health complications such as asthma, skin irritation and respiratory issues can ...

Modeling data show Cologuard PlusTM test delivers highest life-years gained with fewest number of colonoscopies among noninvasive colorectal cancer (CRC) screening strategies “Exact Sciences is ...

“Exact Sciences is pleased to share new modeling data which demonstrates the Cologuard Plus test as an efficient CRC ... with an average of 25.5 days to return the kit; This supports mt-sDNA ...

But the new, just-launched version of its Cologuard test could spur top-line growth ... that some physicians hesitated to prescribe the previous version of Cologuard because of a relatively ...

This approach contributed to strong growth in Cologuard test utilization among rescreen patients and within care gap programs during the third quarter. Exact Sciences received FDA approval for the ...